Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Wyeth-Ayerst to market Abelcet in Greece

July 29, 1998

Dura acquires U.S. marketing rights to Myambutol

July 28, 1998

NDA filed for magainin antibiotic for infected diabetic foot ulcers

July 28, 1998

Daiichi patents compounds for enhancing bacterial sensitivity to antimicrobial agents

July 28, 1998

FDA approves new dosing regimen for SB's amoxicillin

July 27, 1998

Bristol-Myers Squibb now marketing Cefzil in U.K.

July 23, 1998

Potent erythromycin derivatives for Gram-positive infections discovered by Taisho

July 23, 1998

French and Israeli researchers synthesize peptides active against slow-growing, anaerobic bacteria

July 22, 1998

Morinaga Milk develops peptides with antifungal activity

July 22, 1998

Erythromycins from Taisho for Gram-positive infections

July 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...